Clinical Trial Update: Suturable DuraGen™ PMCF Study

View source ↗

Summary

This post-market clinical follow-up study evaluating Suturable DuraGen for preventing cerebrospinal fluid leaks has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrospinal Fluid Leak

Drugs mentioned

• DuraGen Suturable

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Cerebrospinal Fluid Leak | Status: COMPLETED